- The secondary FLT3-ITD F691L mutation induces resistance to AC220 in FLT3-ITD+ AML but retains in vitro sensitivity to PKC412 and Sunitinib.
The secondary FLT3-ITD F691L mutation induces resistance to AC220 in FLT3-ITD+ AML but retains in vitro sensitivity to PKC412 and Sunitinib.
Leukemia (2013-02-09)
C Albers, H Leischner, M Verbeek, C Yu, A L Illert, C Peschel, N von Bubnoff, J Duyster
PMID23392356